Prosecution Insights
Prosecution Insights
Tech Center 1700 • Art Units: 1637 1653 1682 1759 1797 1798
This examiner grants 53% of resolved cases
Sean C. Barron is an examiner in Tech Center 1700 and Art Unit 1637. He has 617 resolved cases. His allowance rate is 53.0 percent. The median days to allowance for his cases is 1322. This 1322-day figure provides a timeline for applicants to expect when their cases are granted.
The interview lift for this examiner is 30.8 percent. This 30.8 percent lift is an increase when compared to the 53.0 percent baseline. It suggests that cases involving an interview have a higher probability of allowance than those that do not. For practitioners in Art Unit 1637, this data point indicates that direct communication is an effective strategy.
With 617 resolved cases, the data for this examiner is established. The allowance rate and median pendency describe the typical outcome and timing for his docket. The interview lift is a significant metric, showing a statistical benefit to conducting an interview during the prosecution process.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18293040 | ENGINEERING AAV VECTORS WITH IMPROVED CNS TARGETING | Non-Final OA | University of Florida Research Foundation, Incorporated |
| 15231586 | RAPID ALLOGRAFT TREATMENT SYSTEMS AND METHODS | Non-Final OA | AlloSource |
| 17761879 | Cell Culture Media Tablets and Methods of Manufacture | Non-Final OA | LIFE TECHNOLOGIES CORPORATION |
| 18705735 | HYDROGEL STRUCTURES AND METHODS OF MAKING AND USE THEREOF | Non-Final OA | GEORGIA TECH RESEARCH CORPORATION |
| 18553234 | METHOD FOR PRODUCING RECYCLED WATER | Final Rejection | KANEKA CORPORATION |
| 18580417 | Methods and Model Systems for Assessing Therapeutic Properties of Candidate Agents and Related Computer Readable Media and Systems | Non-Final OA | The Regents of the University of California |
| 18315370 | MICROFLUDIC LAB-ON-CHIP DEVICE, MATRIX, SMALL MOLECULES AND THREE-DIMENSIONAL SPHEROIDS FOR CELL REPROGRAMMING | Non-Final OA | The Regents of the University of California |
| 16772865 | A METHOD FOR STABILIZING CELL CULTURE SYSTEMS USING AN AMPHIPHILIC GRAFT COPOLYMER AS CELL CULTURE REAGENT | Non-Final OA | BASF SE |
| 18561236 | MULTI-REGIONAL HUMAN NEURAL CIRCUITS IN ASSEMBLOIDS DERIVED FROM PLURIPOTENT STEM CELLS | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 17440618 | CONTROL OF NITROGEN FIXATION IN RHIZOBIA THAT ASSOCIATE WITH CEREALS | Final Rejection | Massachusetts Institute of Technology |
| 16634076 | METHOD FOR ISOLATING EXTRACELLULAR VESICLE USING HYDROPHOBIC INTERACTION | Final Rejection | POSTECH RESEARCH AND BUSINESS DEVELOPMENT FOUNDATION |
| 18575437 | FLUID SHEAR STRESS FOR EX VIVO ACTIVATION OF IMMUNE EFFECTOR CELLS | Non-Final OA | Vanderbilt University |
| 18652720 | CELL DISSOCIATION DEVICE AND METHOD | Non-Final OA | Bayer Aktiengesellschaft |
| 17419274 | CHEMICALLY PROGRAMMED NEUTROPHILS AND USES THEREOF | Non-Final OA | VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. |
| 17781279 | Nerve Xenografts and Related Methods | Non-Final OA | The General Hospital Corporation |
| 18708373 | COMPOSITION COMPRISING DECELLULARIZED UTERINE TISSUE-DERIVED EXTRACELLULAR MATRIX AND USE THEREOF | Non-Final OA | Industry-Academic Cooperation Foundation, YONSEI UNIVERSITY |
| 18657915 | DRIVING AXON REGENERATION BY NRF2 OVEREXPRESSION AND EDARAVONE APPLICATION | Non-Final OA | The Hong Kong University of Science and Technology |
| 18687438 | METHODS AND COMPOSITION FOR TREATING NEURODEGENERATIVE DISEASES | Non-Final OA | Case Western Reserve University |
| 18565862 | PREPARATION AND STANDARDIZATION OF CELL SPHEROIDS FOR PROMOTING TISSUE REGENERATION | Final Rejection | SEOUL NATIONAL UNIVERSITY HOSPITAL |
| 18717244 | METHODS AND SYSTEMS FOR TRANSFECTING HOST CELLS | Non-Final OA | Biogen MA Inc. |
| 18334454 | PERFUSION MEDIUM | Final Rejection | Boehringer Ingelheim International GmbH |
| 18712323 | COMPOSITIONS AND METHODS FOR TREATMENT OF FABRY DISEASE | Non-Final OA | The Trustees of the University of Pennsylvania |
| 18687571 | METHODS FOR EVALUATING TREATMENTS FOR BESTROPHINOPATHIES | Non-Final OA | The Trustees of the University of Pennsylvania |
| 17633498 | METHODS FOR IMPROVED EXTRACTION OF SPIDER SILK PROTEINS | Non-Final OA | Bolt Threads, Inc. |
| 18404446 | RECOMBINANT LACTATE DEHYDROGENASE AND USES THEREOF | Non-Final OA | B. G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD., AT BEN-GURION UNIVERSITY |
| 18717354 | METHOD FOR PRODUCING NEURAL CREST CELLS SPECIALIZED FOR DIFFERENTIATION INTO MESENCHYMAL LINEAGE | Non-Final OA | Kyoto University |
| 18580107 | METHOD FOR CRYOPRESERVATION OF SOLID TUMOR FRAGMENTS | Final Rejection | IOVANCE BIOTHERAPEUTICS, INC |
| 18687608 | COMPOSITIONS AND METHODS FOR CELL REPROGRAMMING | Non-Final OA | CORNELL UNIVERSITY |
| 17259792 | NEW BACTERIA | Final Rejection | Chr. Hansen A/S |
| 18576307 | RECOMBINANT MICROORGANISM-BASED METHODS AND COMPOSITIONS FOR TREATMENT OF DISEASE | Non-Final OA | Baylor College of Medicine |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy